Skip to main content

Table 4 Asthma patients without obesity: differences in pulmonary function between patients with and without increased FeNO (n = 224)

From: Pulmonary function, exhaled nitric oxide and symptoms in asthma patients with obesity: a cross-sectional study

 

FeNO < 25 ppb n = 167

FeNO ≥ 25 ppb n = 57

Unadjusted difference (95% CI)a

Adjusted difference (95% CI)a

Lung function

 FEV1, % pred, mean (SD)

101.5 (17.7)

95.2 (18.7)

−6.4 (−11.8, −0.9)

−4.4 (−9.7, 0.9)

 FVC, % pred, mean (SD)

112.9 (17.9)

108.5 (18.5)

−4.4 (−9.7, 1.0)

−1.6 (−6.6, 3.4)

 FEV1/FVC, mean (SD)

74.5 (8.0)

72.2 (8.4)

−2.3 (−4.8, 0.1)

−1.9 (−4.4, 0.6)

Symptoms

 Dyspnea, n (%)

60 (36)

18 (32)

−4.3 (−18.6, 9.9)

−1.1 (−15.4, 13.3)

 Wheezing, n (%)

31 (19)

8 (14)

−4.5 (−15.4, 6.4)

−6.4 (−17.5, 4.8)

 Coughing with mucus, n (%)

41 (26)

8 (14)

−10.5 (−21.8, 0.7)

−10.5 (−21.9, 1.0)

 Coughing without mucus, n (%)

58 (35)

14 (26)

−10.2 (−23.6, 3.3)

−12.2 (−24.5, 0.1)

Symptoms worsen during:

 Physical activity, n (%)

62 (37)

15 (26)

−10.8 (−24.5, 2.9)

−11.1 (−24.2, 2.1)

 Dust/pollen/animal exposure, n (%)

58 (35)

21 (37)

2.1 (−12.5, 16.7)

5.5 (−8.8, 19.8)

 Foggy weather, n (%)

61 (37)

17 (30)

−6.7 (−20.8, 7.4)

−2.4 (−15.6, 10.7)

 Night, n (%)

17 (10)

9 (16)

5.6 (−5.0, 16.2)

4.4 (−6.5, 15.3)

 Getting up in the morning, n (%)

24 (14)

9 (16)

1.4 (−9.5, 12.4)

0.7 (−9.9, 11.4)

ICS prescription, n (%)

83 (50)

24 (42)

−7.6 (−22.7, 7.5)

−8.6 (−24.0, 6.7)

  1. Fe NO fractional exhaled nitric oxide, CI confidence interval, FEV 1 forced expiratory volume in one second, FVC forced vital capacity, ppb parts per billion, ICS inhalation corticosteroids
  2. aDifferences are presented as difference in means for continuous variables and difference in percentage for categorical variables
  3. Analyses are adjusted for age, sex, smoking, education levels, ethnicity, physical activity, alcohol use, and prescription of ICS